NOS3 and cancer: Our findings indicate no significant association between these NOS3 polymorphisms and either the susceptibility to DTC (Table 3) or the progression and clinical outcomes of the disease (Table 7), despite the established roles of NOS3 in NO production and the increased cancer susceptibility that NOS3 polymorphisms might promote.